SCHEMBL4356145

SCHEMBL4356145

Nc1ncnc2nc(-c3ccccn3)c(-c3ccccn3)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 4/20 0.53
PI4KA P42356 1/20 0.52
PI4K2B Q8TCG2 1/20 0.52
PI4K2A Q9BTU6 1/20 0.52
PI4KB Q9UBF8 1/20 0.52
ADK P55263 1/20 0.51
KDM4E B2RXH2 5/20 0.44
NPC1 O15118 1/20 0.44
ULK1 O75385 1/20 0.43
CDK7 P50613 1/20 0.43
CDK5 Q00535 1/20 0.43
PRKCE Q02156 1/20 0.43
CAMK2G Q13555 1/20 0.43
DYRK1A Q13627 1/20 0.43
CDK5R1 Q15078 1/20 0.43
RPS6KA1 Q15418 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
MAP3K19 Q56UN5 1/20 0.43
CAMKK1 Q8N5S9 1/20 0.43
CAMKK2 Q96RR4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13019018 0.87 PIK3CG (0.50) PIK3CGPI4KAPI4K2BPI4K2API4KB
Sulfuric Acid SCHEMBL3740961 0.81 PIK3CG (0.47) PIK3CGPI4KAPI4K2BPI4K2API4KB
SCHEMBL3742316 0.78 ADK (0.76) PIK3CGPI4KAPI4K2BPI4K2API4KB
SCHEMBL12014918 0.73 MCL1 (0.38) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL16597187 0.73 KDM4E (0.56) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL323086 0.72 KDM4E (0.68) KDM4ENPC1ULK1CDK7CDK5
SCHEMBL6761875 0.70 KDM4E (0.53) KDM4ENPC1ULK1CDK7CDK5
SCHEMBL3532692 0.69 PIK3CG (1.00) PIK3CGPI4KBADKDYRK1ARPS6KA1
SCHEMBL13019047 0.69 KDM4E (0.53) KDM4ENPC1ULK1CDK7CDK5
SCHEMBL12763675 0.68 KDM4E (0.54) KDM4ENPC1ULK1CDK7CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039683-B1 Vasculostatic agents and methods of use thereof TARGEGEN INC (US) 2012-12-19 EP disclosed
EP-2039683-A2 Vasculostatic agents and methods of use thereof Targegen, Inc. (US) 2009-03-25 EP disclosed